-
1 Comment
Guangzhou Kingmed Diagnostics Group Co., Ltd is currently in a long term uptrend where the price is trading 7.1% above its 200 day moving average.
From a valuation standpoint, the stock is 9.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.7.
Guangzhou Kingmed Diagnostics Group Co., Ltd's total revenue rose by 70.8% to $2B since the same quarter in the previous year.
Its net income has increased by 238.7% to $499M since the same quarter in the previous year.
Finally, its free cash flow grew by 347.8% to $546M since the same quarter in the previous year.
Based on the above factors, Guangzhou Kingmed Diagnostics Group Co., Ltd gets an overall score of 5/5.
| Sector | Healthcare |
|---|---|
| Industry | Diagnostics & Research |
| ISIN | CNE100002VW1 |
| Exchange | SHG |
| CurrencyCode | CNY |
| Beta | 0.91 |
|---|---|
| Market Cap | 13B |
| Target Price | 41.3 |
| PE Ratio | 82.89 |
| Dividend Yield | None |
Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. The company also offers clinical research, health management, cold chain logistics, and scientific research services, as well as vitro diagnostics, big data, artificial intelligence, and forensic testing services. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603882.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
